HAVCR2
Hepatitis A virus cellular receptor 2
Also known as: CD366, FLJ14428, HAVR2_HUMAN, Tim-3, TIM3, TIMD3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TDQ0
- Gene
- HAVCR2
- Ensembl
- ENSG00000135077
- Chromosome
- 5
- Canonical length
- 301 aa
- Protein class
- CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
The protein encoded by this gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
301 residues, UniProt reviewed canonical sequence.
>Q8TDQ0|HAVCR2
1 MFSHLPFDCV LLLLLLLLTR SSEVEYRAEV GQNAYLPCFY TPAAPGNLVP VCWGKGACPV
61 FECGNVVLRT DERDVNYWTS RYWLNGDFRK GDVSLTIENV TLADSGIYCC RIQIPGIMND
121 EKFNLKLVIK PAKVTPAPTR QRDFTAAFPR MLTTRGHGPA ETQTLGSLPD INLTQISTLA
181 NELRDSRLAN DLRDSGATIR IGIYIGAGIC AGLALALIFG ALIFKWYSHS KEKIQNLSLI
241 SLANLPPSGL ANAVAEGIRS EENIYTIEEN VYEVEEPNEY YCYVSSRQQP SQPLGCRFAM
301 PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HAVCR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 27 nTPM
- kidney: 24 nTPM
- spleen: 21 nTPM
- lung: 20 nTPM
- spinal cord: 18 nTPM
- appendix: 17 nTPM
Single-cell type
- microglia: 221 nCPM
- hofbauer cells: 197 nCPM
- kupffer cells: 192 nCPM
- macrophages: 176 nCPM
- nk-cells: 175 nCPM
- monocytes: 168 nCPM
Immune cell
- myeloid DC: 119 nTPM
- NK-cell: 76 nTPM
- intermediate monocyte: 63 nTPM
- classical monocyte: 57 nTPM
- non-classical monocyte: 46 nTPM
- total PBMC: 39 nTPM
Brain region
- white matter: 52 nTPM
- thalamus: 35 nTPM
- medulla oblongata: 35 nTPM
- pons: 30 nTPM
- spinal cord: 30 nTPM
- midbrain: 22 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HAVCR2.
Disease | AllUniProt
Conditions HAVCR2 is implicated in, by any mechanism.
- T-cell lymphoma, subcutaneous panniculitis-like (SPTCL) MIM:618398
ReferencesPubMed · IEDB
Publications for HAVCR2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation.
2009 · Blood · RCR 7 · 371 citations - T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
2010 · J Hepatol · RCR 4.3 · 197 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- cellular response to lipopolysaccharide
- defense response to Gram-positive bacterium
- inflammatory response
- innate immune response
- macrophage activation involved in immune response
- maternal process involved in female pregnancy
- natural killer cell tolerance induction
- negative regulation of defense response to bacterium
- negative regulation of gene expression
- negative regulation of immunological synapse formation
- negative regulation of interferon-alpha production
- negative regulation of interleukin-2 production
- negative regulation of interleukin-6 production
- negative regulation of myeloid dendritic cell activation
- negative regulation of natural killer cell activation
- negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target
- negative regulation of NF-kappaB transcription factor activity
- negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell
- negative regulation of T cell proliferation
- negative regulation of T-helper 1 type immune response
- negative regulation of tumor necrosis factor production
- negative regulation of type II interferon production
- positive regulation of chemokine production
- positive regulation of defense response to bacterium
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of interleukin-1 production
- positive regulation of interleukin-4 production
- positive regulation of macrophage activation
- positive regulation of non-canonical NF-kappaB signal transduction
- positive regulation of T cell proliferation
- positive regulation of tumor necrosis factor production
- positive regulation of type II interferon production
- regulation of transcription by RNA polymerase II
- toll-like receptor 3 signaling pathway
- toll-like receptor 7 signaling pathway
- toll-like receptor 9 signaling pathway
- negative regulation of granulocyte colony-stimulating factor production
- negative regulation of interleukin-3 production
- regulation of tolerance induction dependent upon immune response
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HAVCR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HAVCR2 as an antibody target. Whether an autoantibody or antibody against HAVCR2 could matter depends on whether native HAVCR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HAVCR2 is annotated at the cell surface, where native HAVCR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HAVCR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...